On-Demand Webinar: Lessons Learned from the Oncology Care Model Implementation
PHE’s latest webinar is now available on-demand:
Lessons Learned from the Oncology Care Model Implementation: Maximizing the Value of Health Economics Evidence—presented by PHE Senior Economist and former Congressional Budget Office Deputy Assistant Director, Dr. James Baumgardner, and PHE Scientific Advisor, Dr. Wade Aubry, former Chief Medical Officer of Blue Shield of California.
- Dr. Aubry addresses how the Oncology Care Model is impacting healthcare systems and insurers
- Learn about the unintended consequences of the Oncology Care Model on healthcare provider decision-making highlighted in recent PHE research led by Dr. Baumgardner
- Understand the opportunities to improve the design and implementation of alternative payment models through the use of health economics research
To view this on-demand webinar, please click here.
By: Jason Shafrin, PhD Sr. Director, Policy and Economics and Jacki Chou, MPL Senior Director, Policy and Economics The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic. Using this single assessment of value in an effort solely to exclude drugs from a major insurance formulary is even more worrisome and fails to recognize the heterogeneity in patient clinical needs and preferences.